These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8938208)
1. Increased prolactin response to buspirone in chronic fatigue syndrome. Sharpe M; Clements A; Hawton K; Young AH; Sargent P; Cowen PJ J Affect Disord; 1996 Nov; 41(1):71-6. PubMed ID: 8938208 [TBL] [Abstract][Full Text] [Related]
2. Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. Malt EA; Olafsson S; Aakvaag A; Lund A; Ursin H J Affect Disord; 2003 Jun; 75(1):77-82. PubMed ID: 12781354 [TBL] [Abstract][Full Text] [Related]
3. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects. Meltzer HY; Maes M Biol Psychiatry; 1994 Mar; 35(5):316-23. PubMed ID: 8011800 [TBL] [Abstract][Full Text] [Related]
4. Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study. Dinan TG; Scott LV; Thakore J; Naesdal J; Keeling PW Psychoneuroendocrinology; 2001 Oct; 26(7):751-6. PubMed ID: 11500255 [TBL] [Abstract][Full Text] [Related]
5. Prolactin response to buspirone was reduced in violent compared to nonviolent parolees. Cherek DR; Moeller FG; Khan-Dawood F; Swann A; Lane SD Psychopharmacology (Berl); 1999 Feb; 142(2):144-8. PubMed ID: 10102766 [TBL] [Abstract][Full Text] [Related]
6. A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity? Condren RM; Dinan TG; Thakore JH Eur Neuropsychopharmacol; 2002 Aug; 12(4):349-54. PubMed ID: 12126875 [TBL] [Abstract][Full Text] [Related]
7. Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment. Gómez-Gil E; Navinés R; Martínez De Osaba MJ; Díaz-Ricart M; Escolar G; Salamero M; Martín-Santos R; Galán A; Gastó C Psychoneuroendocrinology; 2010 May; 35(4):481-9. PubMed ID: 19762159 [TBL] [Abstract][Full Text] [Related]
8. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder. Cubała WJ; Landowski J J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672 [TBL] [Abstract][Full Text] [Related]
9. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871 [TBL] [Abstract][Full Text] [Related]
10. The effects of buspirone on perceived exertion and time to fatigue in man. Marvin G; Sharma A; Aston W; Field C; Kendall MJ; Jones DA Exp Physiol; 1997 Nov; 82(6):1057-60. PubMed ID: 9413736 [TBL] [Abstract][Full Text] [Related]
11. Central 5-HT receptor hypersensitivity in migraine without aura. Cassidy EM; Tomkins E; Dinan T; Hardiman O; O'Keane V Cephalalgia; 2003 Feb; 23(1):29-34. PubMed ID: 12534577 [TBL] [Abstract][Full Text] [Related]
12. Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation. Blier P; Seletti B; Gilbert F; Young SN; Benkelfat C Neuropsychopharmacology; 2002 Aug; 27(2):301-8. PubMed ID: 12093604 [TBL] [Abstract][Full Text] [Related]
13. Serotonin supersensitivity: the pathophysiologic basis of non-ulcer dyspepsia? A preliminary report of buspirone/prolactin responses. Dinan TG; Yatham LN; Barry S; Chua A; Keeling PW Scand J Gastroenterol; 1990 May; 25(5):541-4. PubMed ID: 2359983 [TBL] [Abstract][Full Text] [Related]
14. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response. Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123 [TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced? Dinan TG; Mahmud N; Rathore O; Thakore J; Scott LV; Carr E; Naesdal J; O'Morain CA; Keeling PW Aliment Pharmacol Ther; 2001 Oct; 15(10):1613-8. PubMed ID: 11564001 [TBL] [Abstract][Full Text] [Related]
16. The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Anderson IM; Deakin JF; Miller HE Psychopharmacology (Berl); 1996 Nov; 128(1):74-82. PubMed ID: 8944409 [TBL] [Abstract][Full Text] [Related]
17. Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxiety. Tollefson GD; Godes M; Montague-Clouse J; Lancaster SP; Garvey MJ J Clin Psychopharmacol; 1989 Apr; 9(2):132-6. PubMed ID: 2723131 [TBL] [Abstract][Full Text] [Related]
18. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans. McAllister-Williams RH; Massey AE Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521 [TBL] [Abstract][Full Text] [Related]
19. Hormonal response to buspirone is not impaired in major depression. Navinés R; Gómez-Gil E; Martín-Santos R; de Osaba MJ; Escolar G; Gastó C Hum Psychopharmacol; 2007 Aug; 22(6):389-95. PubMed ID: 17563921 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists. Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]